Cargando…

Elevation of CA 19-9 in Mirizzi Syndrome in the Absence of Malignancy: A Case Report

Patient: Male, 71-year-old Final Diagnosis: Mirizzi syndrome Symptoms: Epigastric pain • fatigue • jaundice Medication: — Clinical Procedure: Laparoscopic cholecystectomy Specialty: Surgery OBJECTIVE: Unusual clinical course BACKGROUND: Mirizzi syndrome (MS) is relatively a rare condition; incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshref, Leena H., Mandili, Rasha Abdulaziz, Almaghrabi, Murouj, Abdulwahab, Rahaf Abdulrashid, AlOsaimy, Rawan A., Miro, Jameel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255084/
https://www.ncbi.nlm.nih.gov/pubmed/34193808
http://dx.doi.org/10.12659/AJCR.931819
Descripción
Sumario:Patient: Male, 71-year-old Final Diagnosis: Mirizzi syndrome Symptoms: Epigastric pain • fatigue • jaundice Medication: — Clinical Procedure: Laparoscopic cholecystectomy Specialty: Surgery OBJECTIVE: Unusual clinical course BACKGROUND: Mirizzi syndrome (MS) is relatively a rare condition; incidence rates may increment with age. It is characterized as an obstruction of the common hepatic duct (CHD) auxiliary to outward compression of an infected stone in the cystic duct. Carbohydrate antigen (CA) 19-9 is a tumor marker that is usually related to upper-gastrointestinal malignancies. However, a few case reports have shown high levels of CA19-9 in the absence of malignancy. In this case, we report a case of a patient with MS, elevated CA19-9, and radiological findings suggesting gallbladder cancer, which shows the challenges of diagnosis and therapeutic procedures. CASE REPORT: We report the case of a 71-year-old Saudi man who presented to the emergency department with signs of obstructive jaundice. Magnetic resonance cholangiopancreatography (MRCP) revealed cholelithiasis, with a huge cystic duct stone compressing the CHD, resulting in mild intra-/extrahepatic biliary dilatation and positive MRCP pearl necklace sign for adenomyomatosis of the gallbladder. Serum tumor markers revealed raised levels of CA19-9 to 21 068 u/ml. The patient underwent laparoscopic cholecystectomy. Biopsy results confirmed the diagnosis of acute calcular cholecystitis and adenomyosis with no malignancy. CONCLUSIONS: We report what can be considered a rare case of Mirizzi syndrome with a very high CA19-9 marker, in an elderly patient, in the absence of malignancy. This illustrates that Mirizzi syndrome and cholangiocarcinoma are difficult to distinguish, and the diagnosis is considered challenging. Thus, a high index of suspension must be kept in mind, especially in elderly patients, to rule out the cause of malignancy and thus to create an appropriate management plan.